BiotechTube

estradiol

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Turner Syndrome

Conditions

Turner Syndrome

Trial Timeline

Jun 1, 2005 → Mar 1, 2013

NCT ID
NCT00134745

About estradiol

estradiol is a approved stage product being developed by Novo Nordisk for Turner Syndrome. The current trial status is completed. This product is registered under clinical trial identifier NCT00134745. Target conditions include Turner Syndrome.

What happened to similar drugs?

2 of 7 similar drugs in Turner Syndrome were approved

Approved (2) Terminated (0) Active (5)
🔄SomatropinEli LillyPhase 3
✅HumatropeEli LillyApproved
🔄17 beta estradiolEli LillyPhase 3
🔄Somatropin + Ethinyl estradiol + Medroxyprogesterone acetateEli LillyPhase 3
✅r-hGHMerckApproved
🔄Somapacitan + Norditropin®Novo NordiskPhase 3
🔄Somatropin (rDNA origin)IpsenPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00134745ApprovedCompleted

Competing Products

10 competing products in Turner Syndrome

See all competitors
ProductCompanyStageHype Score
SomatropinEli LillyPhase 3
40
HumatropeEli LillyApproved
43
17 beta estradiolEli LillyPhase 3
40
Somatropin + Ethinyl estradiol + Medroxyprogesterone acetateEli LillyPhase 3
40
r-hGHMerckApproved
43
Somapacitan + Norditropin®Novo NordiskPhase 3
44
Norditropin, Menostar 14mcg patch, Vivelle dot 25mcg patchNovo NordiskPhase 1
21
somatotropinPfizerPre-clinical
26
Lonapegsomatropin + SomatropinAscendis PharmaPhase 2
36
Somatropin (rDNA origin)IpsenPhase 3
37